BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26099528)

  • 21. Observational methods in comparative effectiveness research.
    Concato J; Lawler EV; Lew RA; Gaziano JM; Aslan M; Huang GD
    Am J Med; 2010 Dec; 123(12 Suppl 1):e16-23. PubMed ID: 21184862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practical guide to understanding Comparative Effectiveness Research (CER).
    Neely JG; Sharon JD; Graboyes EM; Paniello RC; Nussenbaum B; Grindler DJ; Dassopoulos T;
    Otolaryngol Head Neck Surg; 2013 Dec; 149(6):804-12. PubMed ID: 24098005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of private industry in pragmatic comparative effectiveness trials.
    Buesching DP; Luce BR; Berger ML
    J Comp Eff Res; 2012 Mar; 1(2):147-56. PubMed ID: 24237375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practice-based evidence research in rehabilitation: an alternative to randomized controlled trials and traditional observational studies.
    Horn SD; DeJong G; Deutscher D
    Arch Phys Med Rehabil; 2012 Aug; 93(8 Suppl):S127-37. PubMed ID: 22840879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical research on traditional drugs and food items--the potential of comparative effectiveness research for interdisciplinary research.
    Witt CM
    J Ethnopharmacol; 2013 May; 147(1):254-8. PubMed ID: 23458921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?
    Li G; Sajobi TT; Menon BK; Korngut L; Lowerison M; James M; Wilton SB; Williamson T; Gill S; Drogos LL; Smith EE; Vohra S; Hill MD; Thabane L;
    J Clin Epidemiol; 2016 Dec; 80():16-24. PubMed ID: 27555082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness research paradigm: implications for systematic reviews and clinical practice guidelines.
    Brouwers MC; Thabane L; Moher D; Straus SE
    J Clin Oncol; 2012 Dec; 30(34):4202-7. PubMed ID: 23071227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementing CER: what will it take?
    Biskupiak JE; Dunn JD; Holtorf AP
    J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S19-29. PubMed ID: 22663296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.
    Berger ML; Dreyer N; Anderson F; Towse A; Sedrakyan A; Normand SL
    Value Health; 2012; 15(2):217-30. PubMed ID: 22433752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Effectiveness Research in Pediatric Respiratory Disease: Promise and Pitfalls.
    Ramos KJ; Somayaji R; Nichols DP; Goss CH
    Paediatr Drugs; 2018 Feb; 20(1):1-7. PubMed ID: 28776129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role and impact of research agendas on the comparative-effectiveness research among antihyperlipidemics.
    Dunn AG; Bourgeois FT; Murthy S; Mandl KD; Day RO; Coiera E
    Clin Pharmacol Ther; 2012 Apr; 91(4):685-91. PubMed ID: 22378152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Overview of design, implementation and analysis of comparative effectiveness research].
    Liao X; Xie YM; Tian F; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Mar; 38(6):930-5. PubMed ID: 23717982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex questions command complex analyses: comparative effectiveness of drug treatment strategies in atrial fibrillation.
    Ionescu-Ittu R; Pilote L
    J Comp Eff Res; 2013 Jan; 2(1):1-4. PubMed ID: 24236513
    [No Abstract]   [Full Text] [Related]  

  • 34. Group sequential designs for developing and testing biomarker-guided personalized therapies in comparative effectiveness research.
    Lai TL; Liao OY; Kim DW
    Contemp Clin Trials; 2013 Nov; 36(2):651-63. PubMed ID: 23994669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.
    Oderda GM; Balfe LM
    J Manag Care Pharm; 2011; 17(9 Suppl B):S19-24. PubMed ID: 22073936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stakeholder assessment of comparative effectiveness research needs for Medicaid populations.
    Fischer MA; Allen-Coleman C; Farrell SF; Schneeweiss S
    J Comp Eff Res; 2015 Sep; 4(5):465-71. PubMed ID: 26388438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative comparative effectiveness research.
    Memtsoudis SG; Besculides MC
    Best Pract Res Clin Anaesthesiol; 2011 Dec; 25(4):535-47. PubMed ID: 22099919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Building useful evidence: changing the clinical research paradigm to account for comparative effectiveness research.
    Greenfield S; Kaplan SH
    J Comp Eff Res; 2012 May; 1(3):263-70. PubMed ID: 23577230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the phase III clinical trial designs of novel oral anticoagulants versus warfarin for the treatment of nonvalvular atrial fibrillation: implications for clinical practice.
    Gonzalez-Quesada CJ; Giugliano RP
    Am J Cardiovasc Drugs; 2014 Apr; 14(2):111-27. PubMed ID: 24504768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New methods for determining comparative effectiveness in rheumatoid arthritis.
    Yun H; Curtis JR
    Curr Opin Rheumatol; 2013 May; 25(3):325-33. PubMed ID: 23508131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.